Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships.

The properties of chemicals are rooted in their molecular structure. It follows that structural analysis of specific interactions between ligands and biomolecules at the molecular level is invaluable for defining structure-activity relationships (SARs) and structure-toxicity relationships (STRs). This study has elucidated the structural and molecular basis of interactions of biomolecules with alkyl and aryl halides that are extensively used as components in many commercial pesticides, disinfectants, and drugs. We analyzed the protein structures deposited in Protein Data Bank (PDB) for structural information associated with interactions between halogenated ligands and proteins. This analysis revealed distinct patterns with respect to the nature and structural characteristics of halogen interactions with specific types of atoms and groups in proteins. Fluorine had the highest propensity of interactions for glycine, while chlorine for leucine, bromine for arginine, and iodine for lysine. Chlorine, bromine and iodine had the lowest propensity of interactions for cysteine, while fluorine had a lowest propensity for proline. These trends for highest propensity shifted towards the hydrophobic residues for all the halogens when only interactions with the side chain were considered. Halogens had equal propensities of interaction for the halogen bonding partners (nitrogen and oxygen atoms), albeit with different geometries. The optimal angle for interactions with halogens was approximately 120 degrees for oxygen atoms, and approximately 96 degrees for nitrogen atoms. The distance distributions of halogens with various amino acids were mostly bimodal, and the angle distributions were unimodal. Insights gained from this study have implications for the rational design of safer drugs and commercially important chemicals.

[1]  P. Thallapally,et al.  A Cambridge Structural Database analysis of the C–H⋯Cl interaction: C–H⋯Cl− and C–H⋯Cl–M often behave as hydrogen bonds but C–H⋯Cl–C is generally a van der Waals interaction , 2001 .

[2]  Christopher A. Hunter,et al.  The nature of .pi.-.pi. interactions , 1990 .

[3]  C. Moyes,et al.  3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists. , 2001, Journal of medicinal chemistry.

[4]  L. Pedersen,et al.  Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferase. , 2003, Environmental health perspectives.

[5]  Yuji Nagata,et al.  Exploring the structure and activity of haloalkane dehalogenase from Sphingomonas paucimobilis UT26: evidence for product- and water-mediated inhibition. , 2002, Biochemistry.

[6]  T W Schultz,et al.  Structure–activity relationships for aquatic toxicity to Tetrahymena: Halogen‐substituted aliphatic esters , 2001, Environmental toxicology.

[7]  P. Gillman,et al.  A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action , 2006, Biological Psychiatry.

[8]  T W Schultz,et al.  Structure-toxicity relationships for selected halogenated aliphatic chemicals. , 1999, Environmental toxicology and pharmacology.

[9]  I. Ahmad,et al.  Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities , 2001, Anti-cancer drugs.

[10]  J. Thornton,et al.  Satisfying hydrogen bonding potential in proteins. , 1994, Journal of molecular biology.

[11]  N Vaidehi,et al.  Stabilization of coiled-coil peptide domains by introduction of trifluoroleucine. , 2001, Biochemistry.

[12]  G. Cruciani,et al.  Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field. , 2004, Journal of medicinal chemistry.

[13]  J. Borlakoglu,et al.  Metabolism of di-, tri-, tetra-, penta- and hexachlorobiphenyls by hepatic microsomes isolated from control animals and animals treated with Aroclor 1254, a commercial mixture of polychlorinated biphenyls (PCBs). , 1993, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

[14]  H. Glatt,et al.  Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. , 2000, Endocrinology.

[15]  P. Brick,et al.  Structural basis for the inhibition of firefly luciferase by a general anesthetic. , 1998, Biophysical journal.

[16]  J Damborsky,et al.  Purification and characterization of a haloalkane dehalogenase of a new substrate class from a gamma-hexachlorocyclohexane-degrading bacterium, Sphingomonas paucimobilis UT26 , 1997, Applied and environmental microbiology.

[17]  I. Collins,et al.  Fluorination of 3‐(3‐(Piperidin‐1‐yl)propyl)indoles and 3‐(3‐(Piperazin‐1‐yl)propyl)indoles Gives Selective Human 5‐HT1D Receptor Ligands with Improved Pharmacokinetic Profiles. , 1999 .

[18]  S. Lippard,et al.  Crystal Structure of the Toluene/o-Xylene Monooxygenase Hydroxylase from Pseudomonas stutzeri OX1 , 2004, Journal of Biological Chemistry.

[19]  Y. Kuroda,et al.  Polychlorinated biphenyls suppress thyroid hormone-induced transactivation. , 2002, Biochemical and biophysical research communications.

[20]  F. Diederich,et al.  Mapping the Fluorophilicity of a Hydrophobic Pocket: Synthesis and Biological Evaluation of Tricyclic Thrombin Inhibitors Directing Fluorinated Alkyl Groups into the P Pocket , 2006, ChemMedChem.

[21]  Manfred Kansy,et al.  Fluorine Interactions at the Thrombin Active Site: Protein Backbone Fragments HCαCO Comprise a Favorable CF Environment and Interactions of CF with Electrophiles , 2004, Chembiochem : a European journal of chemical biology.

[22]  J. G. Vinter,et al.  Quantitative determination of intermolecular interactions with fluorinated aromatic rings. , 2001, Chemistry.

[23]  F. Diederich,et al.  Interactions with aromatic rings in chemical and biological recognition. , 2003, Angewandte Chemie.

[24]  J. Clader,et al.  Discovery of 1‐(4‐Fluorophenyl)‐(3R)‐ [3‐(4‐fluorophenyl)‐(3S)‐hydroxypropyl] ‐(4S)‐(4‐hydroxyphenyl)‐2‐azetidinone (SCH 58235): A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption. , 1998 .

[25]  T. Steiner.  Hydrogen-Bond Distances to Halide Ions in Organic and Organometallic Crystal Structures: Up-to-date Database Study , 1998 .

[26]  F. Diederich,et al.  A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactions. , 2004, Organic & biomolecular chemistry.

[27]  P. Bozeman,et al.  Oxidation of Bromide by the Human Leukocyte Enzymes Myeloperoxidase and Eosinophil Peroxidase , 1995, The Journal of Biological Chemistry.

[28]  Robert Huber,et al.  Crystallographic Evidence for Isomeric Chromophores in 3‐Fluorotyrosyl‐Green Fluorescent Protein , 2004, Chembiochem : a European journal of chemical biology.

[29]  D. Davey,et al.  Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[30]  S. Lippard,et al.  Xenon and halogenated alkanes track putative substrate binding cavities in the soluble methane monooxygenase hydroxylase. , 2001, Biochemistry.

[31]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[32]  S. Dworetzky,et al.  Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition. , 2003, Journal of medicinal chemistry.

[33]  H. Wajant,et al.  Structure of hydroxynitrile lyase from Manihot esculenta in complex with substrates acetone and chloroacetone: implications for the mechanism of cyanogenesis. , 2000, Acta crystallographica. Section D, Biological crystallography.

[34]  The Geometry of Intermolecular Interactions in Some Crystalline Fluorine-Containing Organic Compounds , 1994 .

[35]  Chu-Young Kim,et al.  Contribution of Fluorine to Protein−Ligand Affinity in the Binding of Fluoroaromatic Inhibitors to Carbonic Anhydrase II , 2000 .

[36]  Peter Gmeiner,et al.  Certain 1,4-Disubstituted Aromatic Piperidines and Piperazines with Extreme Selectivity for the Dopamine D4 Receptor Interact with a Common Receptor Microdomain , 2004, Molecular Pharmacology.

[37]  F. Grün,et al.  Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR). , 2003, Environmental health perspectives.

[38]  F. Viani,et al.  The Influence of Fluorinated Molecules (Semiochemicals and Enzyme Substrate Analogues) on the Insect Communication System , 2004, Chembiochem : a European journal of chemical biology.

[39]  A M Vinggaard,et al.  Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. , 2001, Toxicology.

[40]  Chung-Eun Ha,et al.  Structural basis of albumin–thyroxine interactions and familial dysalbuminemic hyperthyroxinemia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[42]  G A Petsko,et al.  Aromatic-aromatic interaction: a mechanism of protein structure stabilization. , 1985, Science.

[43]  R. Bartzatt.  Two lead drug designs based on chloramphenicol as the parent structure, which express alkylation activity with potential for clinical applications , 2003, The Journal of pharmacy and pharmacology.

[44]  Eric Westhof,et al.  Halogen bonds in biological molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Marsh,et al.  Fluorous effect in proteins: de novo design and characterization of a four-alpha-helix bundle protein containing hexafluoroleucine. , 2004, Biochemistry.